Public Employees Retirement System of Ohio Sells 1,189 Shares of CME Group Inc. $CME

Public Employees Retirement System of Ohio lowered its stake in shares of CME Group Inc. (NASDAQ:CME) by 0.8% during the 2nd quarter, HoldingsChannel.com reports. The firm owned 146,685 shares of the financial services provider’s stock after selling 1,189 shares during the quarter. Public Employees Retirement System of Ohio’s holdings in CME Group were worth $40,429,000 at the end of the most recent quarter.

Several other large investors have also recently modified their holdings of CME. B. Riley Wealth Advisors Inc. increased its position in shares of CME Group by 2.5% during the 4th quarter. B. Riley Wealth Advisors Inc. now owns 2,991 shares of the financial services provider’s stock valued at $711,000 after purchasing an additional 72 shares during the last quarter. Universal Beteiligungs und Servicegesellschaft mbH bought a new position in shares of CME Group during the 4th quarter valued at approximately $59,241,000. Lansforsakringar Fondforvaltning AB publ bought a new position in shares of CME Group during the 4th quarter valued at approximately $27,772,000. NorthCrest Asset Manangement LLC grew its position in CME Group by 6.1% in the 4th quarter. NorthCrest Asset Manangement LLC now owns 11,147 shares of the financial services provider’s stock valued at $2,589,000 after acquiring an additional 640 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC grew its position in CME Group by 4.3% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 64,452 shares of the financial services provider’s stock valued at $14,968,000 after acquiring an additional 2,686 shares during the last quarter. Institutional investors own 87.75% of the company’s stock.

Insider Transactions at CME Group

In related news, General Counsel Jonathan L. Marcus sold 392 shares of the firm’s stock in a transaction dated Thursday, September 18th. The stock was sold at an average price of $262.00, for a total transaction of $102,704.00. Following the sale, the general counsel owned 7,851 shares of the company’s stock, valued at $2,056,962. This trade represents a 4.76% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Sunil Cutinho sold 11,896 shares of the firm’s stock in a transaction dated Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total value of $3,229,407.12. Following the sale, the insider directly owned 17,440 shares in the company, valued at approximately $4,734,436.80. The trade was a 40.55% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 13,043 shares of company stock valued at $3,527,956. 0.30% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on CME. UBS Group lowered their target price on shares of CME Group from $305.00 to $285.00 and set a “neutral” rating for the company in a research note on Monday, September 8th. Citigroup boosted their target price on shares of CME Group from $265.00 to $275.00 and gave the company a “neutral” rating in a research note on Thursday, July 3rd. Wall Street Zen lowered shares of CME Group from a “hold” rating to a “sell” rating in a research note on Sunday, July 13th. Piper Sandler boosted their target price on shares of CME Group from $283.00 to $296.00 and gave the company an “overweight” rating in a research note on Tuesday, July 15th. Finally, Oppenheimer boosted their target price on shares of CME Group from $300.00 to $303.00 and gave the company an “outperform” rating in a research note on Thursday, July 24th. Four equities research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have given a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $260.60.

CME Group Price Performance

CME opened at $264.43 on Thursday. CME Group Inc. has a 12-month low of $213.94 and a 12-month high of $290.79. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. The business’s fifty day simple moving average is $271.14 and its 200-day simple moving average is $270.75. The company has a market capitalization of $95.30 billion, a price-to-earnings ratio of 25.60, a PEG ratio of 4.74 and a beta of 0.43.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.91 by $0.05. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The business had revenue of $1.69 billion for the quarter, compared to the consensus estimate of $1.68 billion. During the same quarter in the prior year, the company earned $2.56 EPS. The business’s revenue was up 10.4% compared to the same quarter last year. On average, equities research analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th will be given a dividend of $1.25 per share. The ex-dividend date of this dividend is Tuesday, September 9th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.9%. CME Group’s dividend payout ratio is presently 48.40%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.